- Nachrichtendetail
-
25.04.2024 14:09:28 - dpa-AFX: *ABBVIE'S RINVOQ OUTPERFORMS DUPIXENT IN ATOPIC DERMATITIS STUDY
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ABBVIE | A1J84E | NYSE | 193,480 | 24.09.24 20:59:43 | -0,350 | -0,18% | 193,460 | 193,500 | 192,950 | 193,830 |
